FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

713463006: Carfilzomib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2016. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3289420010 Carfilzomib en Synonym Active Entire term case insensitive SNOMED CT core module
3289481011 Carfilzomib (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carfilzomib Is a Substance with proteasome inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Carfilzomib Has disposition Proteasome inhibitor true Inferred relationship Existential restriction modifier
Carfilzomib Is a Immunologic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing carfilzomib Has active ingredient True Carfilzomib Inferred relationship Existential restriction modifier 1
Product containing carfilzomib in parenteral dose form (medicinal product form) Has active ingredient True Carfilzomib Inferred relationship Existential restriction modifier 1
Carfilzomib Has active ingredient True Carfilzomib Inferred relationship Existential restriction modifier 1
Product containing only carfilzomib in parenteral dose form (medicinal product form) Has active ingredient True Carfilzomib Inferred relationship Existential restriction modifier 1
Product containing precisely carfilzomib 60 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Carfilzomib Inferred relationship Existential restriction modifier 1
Product containing precisely carfilzomib 60 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance True Carfilzomib Inferred relationship Existential restriction modifier 1
Product containing precisely carfilzomib 10 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Carfilzomib Inferred relationship Existential restriction modifier 1
Product containing precisely carfilzomib 10 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance True Carfilzomib Inferred relationship Existential restriction modifier 1
Product containing precisely carfilzomib 30 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Carfilzomib Inferred relationship Existential restriction modifier 1
Product containing precisely carfilzomib 30 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance True Carfilzomib Inferred relationship Existential restriction modifier 1
Kyprolis 60mg powder for solution for infusion vials (Originalis B.V.) 1 vial Has specific active ingredient True Carfilzomib Inferred relationship Existential restriction modifier
Kyprolis 60mg powder for solution for infusion vials (Originalis B.V.) Has specific active ingredient True Carfilzomib Inferred relationship Existential restriction modifier
Carfilzomib 60mg powder for solution for infusion vials Has specific active ingredient True Carfilzomib Inferred relationship Existential restriction modifier
Kyprolis 60mg powder for solution for infusion vials (Amgen Ltd) Has specific active ingredient True Carfilzomib Inferred relationship Existential restriction modifier
Carfilzomib 60mg powder for solution for infusion vials 1 vial Has specific active ingredient True Carfilzomib Inferred relationship Existential restriction modifier
Kyprolis 60mg powder for solution for infusion vials (Amgen Ltd) 1 vial Has specific active ingredient True Carfilzomib Inferred relationship Existential restriction modifier
Carfilzomib 60mg powder for solution for infusion vials Has active ingredient False Carfilzomib Inferred relationship Existential restriction modifier
Kyprolis 60mg powder for solution for infusion vials (Amgen Ltd) Has active ingredient True Carfilzomib Inferred relationship Existential restriction modifier
Carfilzomib 10mg powder for solution for infusion vials Has active ingredient False Carfilzomib Inferred relationship Existential restriction modifier
Carfilzomib 10mg powder for solution for infusion vials Has specific active ingredient True Carfilzomib Inferred relationship Existential restriction modifier
Carfilzomib 30mg powder for solution for infusion vials Has active ingredient False Carfilzomib Inferred relationship Existential restriction modifier
Carfilzomib 30mg powder for solution for infusion vials Has specific active ingredient True Carfilzomib Inferred relationship Existential restriction modifier
Kyprolis 10mg powder for solution for infusion vials (Amgen Ltd) Has active ingredient True Carfilzomib Inferred relationship Existential restriction modifier
Kyprolis 10mg powder for solution for infusion vials (Amgen Ltd) Has specific active ingredient True Carfilzomib Inferred relationship Existential restriction modifier
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) Has active ingredient True Carfilzomib Inferred relationship Existential restriction modifier
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) Has specific active ingredient True Carfilzomib Inferred relationship Existential restriction modifier
Carfilzomib 30mg powder for solution for infusion vials 1 vial Has specific active ingredient True Carfilzomib Inferred relationship Existential restriction modifier
Carfilzomib 10mg powder for solution for infusion vials 1 vial Has specific active ingredient True Carfilzomib Inferred relationship Existential restriction modifier
Kyprolis 10mg powder for solution for infusion vials (Amgen Ltd) 1 vial Has specific active ingredient True Carfilzomib Inferred relationship Existential restriction modifier
Kyprolis 30mg powder for solution for infusion vials (Amgen Ltd) 1 vial Has specific active ingredient True Carfilzomib Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start